SCHEMBL19610440

SCHEMBL19610440

Cn1c(-c2ncc[nH]2)cc2sccc21

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM1A O60341 12/20 0.56
ADORA2A P29274 2/20 0.36
ADORA1 P30542 2/20 0.36
RCOR1 Q9UKL0 2/20 0.36
NISCH Q9Y2I1 2/20 0.36
BRD4 O60885 1/20 0.35
MEN1 O00255 1/20 0.35
NPC1 O15118 1/20 0.35
CYP1A2 P05177 1/20 0.35
CYP3A4 P08684 1/20 0.35
CYP2D6 P10635 1/20 0.35
MAPT P10636 1/20 0.35
CYP2C9 P11712 1/20 0.35
CYP2C19 P33261 1/20 0.35
RAB9A P51151 1/20 0.35
KMT2A Q03164 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
PIM1 P11309 1/20 0.34
MTOR P42345 1/20 0.34
ADK P55263 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19610331 0.75 KDM1A (0.52) KDM1ARCOR1MEN1NPC1CYP1A2
SCHEMBL19610168 0.73 KDM1A (0.61) KDM1ARAB9ATSHR
SCHEMBL30543445 0.73 KMT2A (0.51) NISCHMEN1NPC1MAPTRAB9A
SCHEMBL4247284 0.73 KMT2A (0.51) NISCHMEN1NPC1MAPTRAB9A
SCHEMBL19610172 0.72 KDM1A (0.56) KDM1AMEN1NPC1MAPTRAB9A
SCHEMBL19610181 0.72 KDM1A (0.47) KDM1ARCOR1TSHRNPSR1
SCHEMBL19610239 0.70 KDM1A (0.60) KDM1ARCOR1MEN1NPC1CYP1A2
SCHEMBL19610374 0.70 KDM1A (0.60) KDM1ANPC1RAB9ASMN1; SMN2ALDH1A1
SCHEMBL19610283 0.69 KDM1A (0.61) KDM1ANPC1RAB9ASMN1; SMN2ALDH1A1
SCHEMBL19610406 0.68 KDM1A (0.52) KDM1ANPC1RAB9ATSHRNPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-109641918-B Imidazoles as inhibitors of histone demethylases 欧洲肿瘤研究所有限责任公司 2021-12-21 CN disclosed
US-10961255-B2 Imidazoles as histone demethylase inhibitors ISTITUTO EUROPEO DI ONCOLOGIA S.R.L. (IT) 2021-03-30 US disclosed
EP-3458460-B1 IMIDAZOLES AS HISTONE DEMETHYLASE INHIBITORS ST EUROPEO DI ONCOLOGIA S R L (IT) 2020-12-09 EP disclosed
US-20200299303-A1 IMIDAZOLES AS HISTONE DEMETHYLASE INHIBITORS ISTITUTO EUROPEO DI ONCOLOGIA S.R.L. (IT) 2020-09-24 US disclosed
US-10562914-B2 Imidazoles as histone demethylase inhibitors ISTITUTO EUROPEO DI ONCOLOGIA S.R.L. (IT) 2020-02-18 US disclosed
US-20190152987-A1 IMIDAZOLES AS HISTONE DEMETHYLASE INHIBITORS ISTITUTO EUROPEO DI ONCOLOGIA S.R.L. (IT) 2019-05-23 US disclosed
EP-3246330-A1 IMIDAZOLES AS HISTONE DEMETHYLASE INHIBITORS Istituto Europeo di Oncologia S.r.l. (IT) 2017-11-22 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190152987-A1 IMIDAZOLES AS HISTONE DEMETHYLASE INHIBITORS KDM1B, KDM1A, DOT1L KDM1A 2/4885ADORA2A 1960/4885ADORA1 799/4885
US-20200299303-A1 IMIDAZOLES AS HISTONE DEMETHYLASE INHIBITORS DOT1L, KDM1B, KDM1A KDM1A 3/4885ADORA2A 1576/4885ADORA1 845/4885
US-10562914-B2 Imidazoles as histone demethylase inhibitors KDM1B, KDM1A, DOT1L KDM1A 2/4885ADORA2A 1960/4885ADORA1 799/4885
US-10961255-B2 Imidazoles as histone demethylase inhibitors DOT1L, KDM1B, KDM1A KDM1A 3/4885ADORA2A 1576/4885ADORA1 845/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.